Denali Therapeutics shares owned by Rafferty Asset Management
Quarter-by-quarter ownership of Denali Therapeutics (DNLI) shares owned by Rafferty Asset Management
from 13F filings
Historical chart of Rafferty Asset Management investment in Denali Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Denali Therapeutics held by Rafferty Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Denali Therapeutics by Rafferty Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-09-30 | $4.7M | 229k | 20.63 |
| 2023-06-30 | $7.3M | 249k | 29.51 |
| 2023-03-31 | $5.9M | 257k | 23.04 |
| 2022-12-31 | $7.9M | 284k | 27.81 |
| 2022-09-30 | $6.4M | 207k | 30.69 |
| 2022-06-30 | $3.0M | 102k | 29.43 |
| 2022-03-31 | $5.7M | 176k | 32.17 |
| 2021-12-31 | $5.4M | 122k | 44.60 |
| 2021-09-30 | $3.0M | 60k | 50.45 |
| 2021-06-30 | $2.7M | 35k | 78.44 |
| 2021-03-31 | $2.9M | 52k | 57.10 |
| 2020-12-31 | $976k | 12k | 83.78 |
| 2020-09-30 | $1.4M | 39k | 35.84 |
| 2020-06-30 | $411k | 17k | 24.18 |
| 2019-12-31 | $500k | 29k | 17.43 |
| 2019-09-30 | $864k | 56k | 15.32 |
| 2019-06-30 | $1.6M | 79k | 20.75 |
| 2019-03-31 | $1.2M | 51k | 23.22 |